Barclays
IBB icon

Barclays’s iShares Biotechnology ETF IBB Stock Holding History

Barclays’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-65,700
Closed -$8.31M – 5598
2025
Q2 		$8.31M Buy
65,700
+45,100
+219% +$5.54M ﹤0.01% 1704
2025
Q1 		$2.63M Sell
20,600
-13,400
-39% -$1.82M ﹤0.01% 2425
2024
Q4 		$4.5M Sell
34,000
-146,300
-81% -$20.6M ﹤0.01% 2261
2024
Q3 		$26.3M Buy
+180,300
New +$26.1M 0.01% 928
2024
Q2 		– Sell
-163,900
Closed -$22.5M – 5065
2024
Q1 		$22.5M Sell
163,900
-238,400
-59% -$32.6M 0.01% 932
2023
Q4 		$54.7M Buy
+402,300
New +$49.1M 0.02% 620
2023
Q2 		– Sell
-202,100
Closed -$26.1M – 4773
2023
Q1 		$26.1M Buy
202,100
+133,700
+195% +$17.5M 0.01% 745
2022
Q4 		$8.98M Buy
+68,400
New +$8.84M ﹤0.01% 1254
2021
Q3 		– Sell
-99,400
Closed -$16.3M – 4859
2021
Q2 		$16.3M Buy
+99,400
New +$15.3M 0.01% 984
2021
Q1 		– Sell
-14,200
Closed -$2.15M – 4927
2020
Q4 		$2.15M Hold
14,200
– – ﹤0.01% 2177
2020
Q3 		$1.92M Hold
14,200
– – ﹤0.01% 2135
2020
Q2 		$1.94M Sell
14,200
-88,500
-86% -$11.3M ﹤0.01% 2153
2020
Q1 		$11.1M Sell
102,700
-21,000
-17% -$2.42M 0.01% 935
2019
Q4 		$14.9M Sell
123,700
-21,800
-15% -$2.43M 0.01% 1125
2019
Q3 		$14.5M Sell
145,500
-48,600
-25% -$5.09M 0.01% 1070
2019
Q2 		$21.2M Buy
194,100
+71,200
+58% +$7.57M 0.01% 896
2019
Q1 		$13.7M Sell
122,900
-206,500
-63% -$22.6M 0.01% 1041
2018
Q4 		$31.8M Buy
329,400
+225,700
+218% +$24M 0.02% 545
2018
Q3 		$12.6M Sell
103,700
-114,400
-52% -$13.5M 0.01% 1128
2018
Q2 		$24M Sell
218,100
-220,500
-50% -$23.6M 0.02% 693
2018
Q1 		$46.8M Sell
438,600
-430,100
-50% -$47.7M 0.04% 447
2017
Q4 		$92.8M Buy
868,700
+373,700
+75% +$39.9M 0.08% 214
2017
Q3 		$55M Sell
495,000
-161,400
-25% -$17.3M 0.06% 268
2017
Q2 		$67.8M Buy
656,400
+304,500
+87% +$30M 0.07% 211
2017
Q1 		$34.4M Buy
351,900
+6,900
+2% +$661K 0.04% 354
2016
Q4 		$30.5M Sell
345,000
-89,400
-21% -$8.14M 0.03% 420
2016
Q3 		$41.9M Buy
434,400
+55,800
+15% +$5.31M 0.05% 297
2016
Q2 		$32.5M Buy
378,600
+130,200
+52% +$11.7M 0.04% 349
2016
Q1 		$21.5M Sell
248,400
-675,000
-73% -$60.4M 0.03% 448
2015
Q4 		$104M Sell
923,400
-169,800
-16% -$18.4M 0.13% 140
2015
Q3 		$110M Buy
1,093,200
+831,600
+318% +$99.7M 0.13% 120
2015
Q2 		$32.1M Sell
261,600
-218,100
-45% -$26.1M 0.04% 444
2015
Q1 		$54.8M Buy
479,700
+289,500
+152% +$31.9M 0.06% 297
2014
Q4 		$19.2M Sell
190,200
-215,700
-53% -$21M 0.02% 787
2014
Q3 		$36.9M Sell
405,900
-200,400
-33% -$17.6M 0.04% 434
2014
Q2 		$51.9M Buy
606,300
+333,600
+122% +$26.3M 0.05% 298
2014
Q1 		$21.5M Buy
272,700
+185,700
+213% +$15.5M 0.02% 643
2013
Q4 		$6.58M Buy
87,000
+9,900
+13% +$702K 0.01% 1588
2013
Q3 		$5.37M Buy
77,100
+21,600
+39% +$1.42M 0.01% 1623
2013
Q2 		$3.22M Buy
+55,500
New +$3.21M ﹤0.01% 2022

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Barclays's IBB Position: Q1 2026 in Review

Barclays reduced its iShares Biotechnology ETF (IBB) stake by 33% in Q1 2026, selling an estimated $37.8M and leaving 450,734 shares worth $76.1M. The position accounts for 0.02% of the portfolio, ranked #590.

Barclays first reported a position in IBB in Q2 2013 and has held it in 52 quarters since. The position peaked at $376M in Q4 2019. 917 funds tracked by Wall St. Rank hold IBB as of Q1 2026.

  • Barclays held 450,734 shares of iShares Biotechnology ETF worth $76.1M as of Q1 2026.
  • Barclays sold 221,207 iShares Biotechnology ETF shares in Q1 2026, an estimated $37.8M.
  • iShares Biotechnology ETF made up 0.02% of Barclays's portfolio in Q1 2026, its #590 holding.
  • Barclays first reported a position in iShares Biotechnology ETF in Q2 2013 and has held it in 52 quarters since.
  • Barclays's iShares Biotechnology ETF position peaked at $376M in Q4 2019.
  • 917 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.